미국 Accegen은 생명과학 연구와 의약품 개발을 지원하기 위해 다양한 세포주와 생물학적 제품을 제공하는 바이오 제품 제조 기업입니다.
제품 설명
ATDC5
제품 번호
ABC-TC5598
제품 특징
TDC5 cells are derived from mouse teratocarcinoma and possess chondrogenic potential, meaning they have the ability to differentiate into chondrocytes—the cells responsible for the formation of cartilage. Cells showed a sequential transition of phenotype in vitro. They encompass stages from mesenchymal condensation to calcification. Bone morphogenetic protein-2 (BMP-2) stimulated the sequential progression of early- and late-phase differentiation. Activation of parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor resulted in inhibition of this differentiation capacity.
Why choose ATDC5 from AcceGen?
Commitment to Excellence: Reflects in negative results for bacterial, fungal, Mycoplasma (PCR), and human pathogens in sterility assessment.
Reliability in Viability: Experience over 95% post-thaw viability, establishing a gold standard for cell line vitality.
Robust Growth Characteristics: Witness robust growth validated through meticulous examinations of: Morphology, Immunocytochemistry.
Undifferentiated Marker Peak: Ensuring undifferentiated markers are at their peak, indicating optimal cell line performance.
ATDC5 has been used utilized as a model system to investigate various aspects of chondrogenesis, cartilage development, and related cellular processes. Researchers study ATDC5 cells to better understand the molecular mechanisms involved in chondrocyte differentiation and to explore potential therapeutic interventions for conditions related to cartilage defects or disorders. Thus, it is regarded as a promising in vitro model to study the factors that influence cell behaviors during chondrogenesis. It also provides insights in exploring signaling pathways related to skeletal development as well as interactions with innovative materials.
Accegen의 모든 제품들을 만나 보세요!
PRODUCTS
MSDS
온라인 견적